Table 4.

Population parameter estimates for piperacillin against P. aeruginosa 1280

ParameterSymbolUnitEstimate (SE)
Growth parameters
 log10 initial inoculumlogcfu0log10 cfu/mL7.14 (0.3%)
 mean generation timek12−1min42.6 (0.6%)
 replication rate constantk21h−150 (fixed)
 log10 (maximum population size)logcfumaxlog10 cfu/mL
  for untreated control arms10.2 (1.2%)
  for piperacillin-treated arms9.48 (0.8%)
Log10 (mutant frequencies)
 for intermediate populationlogMFI−3.53 (0.9%)
 for resistant populationlogMFR−6.33 (0.7%)
Inhibition of growth rate by piperacillin
 maximum inhibition
  for susceptible populationImaxk12,S0.760 (2.9%)
  for intermediate populationImaxk12,I0.970 (2.8%)
  for resistant populationImaxk12,R0.285 (28.4%)
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50k12,Smg/L0.877 (20.9%)
  for intermediate populationIC50k12,Img/L5.96 (5.6%)
  for resistant populationIC50k12,Rmg/L23.7 (2.2%)
 Hill coefficienthillk124.67 (10.9%)
Inhibition of probability of successful replication by piperacillin
 maximum inhibitionImaxRep1.0 (fixed)a
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50Rep,Smg/L0.831 (21.9%)
  for intermediate and resistant populationIC50Rep,IRmg/L45.8 (0.5%)
 Hill coefficienthillRep2.43 (3%)
Standard deviation of additive residual error on log10 scaleSDcfulog10 cfu/mL0.259
ParameterSymbolUnitEstimate (SE)
Growth parameters
 log10 initial inoculumlogcfu0log10 cfu/mL7.14 (0.3%)
 mean generation timek12−1min42.6 (0.6%)
 replication rate constantk21h−150 (fixed)
 log10 (maximum population size)logcfumaxlog10 cfu/mL
  for untreated control arms10.2 (1.2%)
  for piperacillin-treated arms9.48 (0.8%)
Log10 (mutant frequencies)
 for intermediate populationlogMFI−3.53 (0.9%)
 for resistant populationlogMFR−6.33 (0.7%)
Inhibition of growth rate by piperacillin
 maximum inhibition
  for susceptible populationImaxk12,S0.760 (2.9%)
  for intermediate populationImaxk12,I0.970 (2.8%)
  for resistant populationImaxk12,R0.285 (28.4%)
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50k12,Smg/L0.877 (20.9%)
  for intermediate populationIC50k12,Img/L5.96 (5.6%)
  for resistant populationIC50k12,Rmg/L23.7 (2.2%)
 Hill coefficienthillk124.67 (10.9%)
Inhibition of probability of successful replication by piperacillin
 maximum inhibitionImaxRep1.0 (fixed)a
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50Rep,Smg/L0.831 (21.9%)
  for intermediate and resistant populationIC50Rep,IRmg/L45.8 (0.5%)
 Hill coefficienthillRep2.43 (3%)
Standard deviation of additive residual error on log10 scaleSDcfulog10 cfu/mL0.259

aImaxRep was estimated at 0.994 and therefore eventually was fixed to 1.0.

Table 4.

Population parameter estimates for piperacillin against P. aeruginosa 1280

ParameterSymbolUnitEstimate (SE)
Growth parameters
 log10 initial inoculumlogcfu0log10 cfu/mL7.14 (0.3%)
 mean generation timek12−1min42.6 (0.6%)
 replication rate constantk21h−150 (fixed)
 log10 (maximum population size)logcfumaxlog10 cfu/mL
  for untreated control arms10.2 (1.2%)
  for piperacillin-treated arms9.48 (0.8%)
Log10 (mutant frequencies)
 for intermediate populationlogMFI−3.53 (0.9%)
 for resistant populationlogMFR−6.33 (0.7%)
Inhibition of growth rate by piperacillin
 maximum inhibition
  for susceptible populationImaxk12,S0.760 (2.9%)
  for intermediate populationImaxk12,I0.970 (2.8%)
  for resistant populationImaxk12,R0.285 (28.4%)
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50k12,Smg/L0.877 (20.9%)
  for intermediate populationIC50k12,Img/L5.96 (5.6%)
  for resistant populationIC50k12,Rmg/L23.7 (2.2%)
 Hill coefficienthillk124.67 (10.9%)
Inhibition of probability of successful replication by piperacillin
 maximum inhibitionImaxRep1.0 (fixed)a
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50Rep,Smg/L0.831 (21.9%)
  for intermediate and resistant populationIC50Rep,IRmg/L45.8 (0.5%)
 Hill coefficienthillRep2.43 (3%)
Standard deviation of additive residual error on log10 scaleSDcfulog10 cfu/mL0.259
ParameterSymbolUnitEstimate (SE)
Growth parameters
 log10 initial inoculumlogcfu0log10 cfu/mL7.14 (0.3%)
 mean generation timek12−1min42.6 (0.6%)
 replication rate constantk21h−150 (fixed)
 log10 (maximum population size)logcfumaxlog10 cfu/mL
  for untreated control arms10.2 (1.2%)
  for piperacillin-treated arms9.48 (0.8%)
Log10 (mutant frequencies)
 for intermediate populationlogMFI−3.53 (0.9%)
 for resistant populationlogMFR−6.33 (0.7%)
Inhibition of growth rate by piperacillin
 maximum inhibition
  for susceptible populationImaxk12,S0.760 (2.9%)
  for intermediate populationImaxk12,I0.970 (2.8%)
  for resistant populationImaxk12,R0.285 (28.4%)
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50k12,Smg/L0.877 (20.9%)
  for intermediate populationIC50k12,Img/L5.96 (5.6%)
  for resistant populationIC50k12,Rmg/L23.7 (2.2%)
 Hill coefficienthillk124.67 (10.9%)
Inhibition of probability of successful replication by piperacillin
 maximum inhibitionImaxRep1.0 (fixed)a
 concentration causing 50% of maximum inhibition
  for susceptible populationIC50Rep,Smg/L0.831 (21.9%)
  for intermediate and resistant populationIC50Rep,IRmg/L45.8 (0.5%)
 Hill coefficienthillRep2.43 (3%)
Standard deviation of additive residual error on log10 scaleSDcfulog10 cfu/mL0.259

aImaxRep was estimated at 0.994 and therefore eventually was fixed to 1.0.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close